Lead Product(s) : Isoxsuprine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Approved FDF
Sponsor : Bharat Serums & Vaccines ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Bharat Serums and Vaccines Acquires Key Women Health Brand Tidilan from Jagdale Industries
Details : Tidilan is currently available in tablet and injectable dosage forms. BSV has some of the leading women’s health brands such as Rhoclone, Hucog, Hucog 5000 HP, AntiD among others.
Product Name : Tidilan
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
May 04, 2022
Lead Product(s) : Isoxsuprine Hydrochloride
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Approved FDF
Sponsor : Bharat Serums & Vaccines ltd
Deal Size : Undisclosed
Deal Type : Acquisition
Reset All
